Skip to main content

Table 4 Baseline and last follow-up data

From: Impact of type 2 diabetes mellitus on mid-term mortality for hypertrophic cardiomyopathy patients who underwent septal myectomy

VariablesNo diabetes (n = 134)Diabetes (n = 67)p value
NYHA class III or IV, n
 Baseline104 (77.6%)54 (80.6%)0.63
 Last follow-up6 (4.5%)7 (10.4%)0.11
Pulmonary hypertension, n
 Baseline17 (12.7%)5 (7.5%)0.26
 Last follow-up3 (2.2%)7 (10.4%)0.02
NSVT, n
 Baseline15 (11.2%)15 (22.4%)0.04
 Last follow-up2 (1.5%)5 (7.5%)0.04
LVOT gradient, mmHg
 Baseline83.3 ± 26.393.2 ± 36.80.03
 Last follow-up11.6 ± 8.412.2 ± 8.50.64
Left atrium ≥ 45 mm, n
 Baseline47 (35.1%)33 (49.3%)0.05
 Last follow-up37 (27.6%)17 (25.4%)0.74
 Death, n4 (3.0%)5 (7.5%)0.16
 Sudden cardiac death, n0 (0%)3 (4.5%)0.04
  1. Values are presented as percentage, mean ± SD, or median (interquartile range) when appropriate
  2. NYHA New York Heart Association, NSVT non-sustained ventricular tachycardia, LVOT left ventricular outflow tract, LVEDD left ventricular end diastole diameter